GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Cyclically Adjusted PB Ratio

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Cyclically Adjusted PB Ratio : (As of Jun. 20, 2024)


View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Skystar Bio-Pharmaceutical Co Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Skystar Bio-Pharmaceutical Co Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2014 is calculated as:

For example, Skystar Bio-Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Sep. 2014 was:

Adj_Book=Book Value per Share/CPI of Sep. 2014 (Change)*Current CPI (Sep. 2014)
=14.414/98.9000*98.9000
=14.414

Current CPI (Sep. 2014) = 98.9000.

Skystar Bio-Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
200412 43.510 74.488 57.770
200503 -14.707 75.597 -19.241
200506 -15.666 74.618 -20.764
200509 -17.664 75.290 -23.203
200512 28.084 75.666 36.707
200603 2.883 76.340 3.735
200606 3.221 76.034 4.190
200609 3.704 76.413 4.794
200612 3.808 77.793 4.841
200703 5.688 78.884 7.131
200706 5.856 79.357 7.298
200709 6.403 81.276 7.791
200712 5.234 82.911 6.243
200803 5.658 85.485 6.546
200806 5.701 85.058 6.629
200809 6.660 85.057 7.744
200812 7.125 83.956 8.393
200903 7.164 84.457 8.389
200906 3.825 83.615 4.524
200909 7.332 84.369 8.595
200912 7.713 85.386 8.934
201003 7.940 86.316 9.098
201006 8.218 85.886 9.463
201009 9.310 87.267 10.551
201012 9.982 89.289 11.056
201103 10.317 91.154 11.194
201106 10.685 91.612 11.535
201109 11.890 92.711 12.684
201112 12.302 92.885 13.099
201203 12.645 94.367 13.252
201206 12.311 93.495 13.023
201209 12.645 94.482 13.236
201212 12.652 95.237 13.139
201303 12.818 96.372 13.154
201306 13.510 95.984 13.920
201309 14.069 97.332 14.296
201312 14.516 97.624 14.706
201403 14.525 98.600 14.569
201406 14.925 98.200 15.031
201409 14.414 98.900 14.414

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Skystar Bio-Pharmaceutical Co  (GREY:SKBI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Skystar Bio-Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines